121 related articles for article (PubMed ID: 27831649)
1. MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance.
Luan QX; Zhang BG; Li XJ; Guo MY
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4257-4265. PubMed ID: 27831649
[TBL] [Abstract][Full Text] [Related]
2. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
3. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
[TBL] [Abstract][Full Text] [Related]
4. MiR-212/132 is epigenetically downregulated by SOX4/EZH2-H3K27me3 feedback loop in ovarian cancer cells.
Lin L; Wang Z; Jin H; Shi H; Lu Z; Qi Z
Tumour Biol; 2016 Nov; ():. PubMed ID: 27812929
[TBL] [Abstract][Full Text] [Related]
5. MiR-375 is epigenetically downregulated due to promoter methylation and modulates multi-drug resistance in breast cancer cells via targeting YBX1.
Liu SL; Sui YF; Lin MZ
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3223-9. PubMed ID: 27466996
[TBL] [Abstract][Full Text] [Related]
6. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
[TBL] [Abstract][Full Text] [Related]
8. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-129-5p modulates epithelial-to-mesenchymal transition by targeting SIP1 and SOX4 during peritoneal dialysis.
Xiao L; Zhou X; Liu F; Hu C; Zhu X; Luo Y; Wang M; Xu X; Yang S; Kanwar YS; Sun L
Lab Invest; 2015 Jul; 95(7):817-832. PubMed ID: 25961171
[TBL] [Abstract][Full Text] [Related]
10. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.
Tiwari N; Tiwari VK; Waldmeier L; Balwierz PJ; Arnold P; Pachkov M; Meyer-Schaller N; Schübeler D; van Nimwegen E; Christofori G
Cancer Cell; 2013 Jun; 23(6):768-83. PubMed ID: 23764001
[TBL] [Abstract][Full Text] [Related]
11. P53-miR-191-
Sharma S; Nagpal N; Ghosh PC; Kulshreshtha R
RNA; 2017 Aug; 23(8):1237-1246. PubMed ID: 28450532
[TBL] [Abstract][Full Text] [Related]
12. MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells.
Li L; Xu QH; Dong YH; Li GX; Yang L; Wang LW; Li HY
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2004-10. PubMed ID: 27249598
[TBL] [Abstract][Full Text] [Related]
13. MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3.
Xiang Y; Liao XH; Yu CX; Yao A; Qin H; Li JP; Hu P; Li H; Guo W; Gu CJ; Zhang TC
Exp Cell Res; 2017 Aug; 357(1):135-144. PubMed ID: 28499590
[TBL] [Abstract][Full Text] [Related]
14. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
15. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
16. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
18. A crucial epithelial to mesenchymal transition regulator, Sox4/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients.
Hasegawa S; Nagano H; Konno M; Eguchi H; Tomokuni A; Tomimaru Y; Asaoka T; Wada H; Hama N; Kawamoto K; Marubashi S; Nishida N; Koseki J; Mori M; Doki Y; Ishii H
Int J Oncol; 2016 Jan; 48(1):145-52. PubMed ID: 26648239
[TBL] [Abstract][Full Text] [Related]
19. miR-760 mediates chemoresistance through inhibition of epithelial mesenchymal transition in breast cancer cells.
Hu SH; Wang CH; Huang ZJ; Liu F; Xu CW; Li XL; Chen GQ
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):5002-5008. PubMed ID: 27981531
[TBL] [Abstract][Full Text] [Related]
20. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
